| Symbol | PALI |
|---|---|
| Name | PALISADE BIO, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Address | 5800 ARMADA DRIVE,SUITE 210, CARLSBAD, California, 92008, United States |
| Telephone | +1 858 704-4900 |
| Fax | — |
| — | |
| Website | https://www.palisadebio.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001357459 |
| Description | Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bios innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery. Additional info from NASDAQ: |
Director Wei Binxian 🟡 adjusted position in 592.3K shares (1 derivative) of PALISADE BIO, INC. (PALI) Transaction Date: Jun 10, 2026 | Filing ID: 028574
Read moreDirector Williams Donald Allen 🟡 adjusted position in 1.5M shares (1 derivative) of PALISADE BIO, INC. (PALI) Transaction Date: Jun 10, 2026 | Filing ID: 028572
Read moreDirector Chuang Emil 🟡 adjusted position in 592.3K shares (1 derivative) of PALISADE BIO, INC. (PALI) Transaction Date: Jun 10, 2026 | Filing ID: 028570
Read moreDirector Zwick Jordan Michael 🟢 acquired 336.9K shares of PALISADE BIO, INC. (PALI) Transaction Date: Jun 10, 2026 | Filing ID: 028568
Read moreNew Form 3 - PALISADE BIO, INC. <b>Filed:</b> 2026-06-12 <b>AccNo:</b> 0001493152-26-028566 <b>Size:</b> 13 KB
Read morePalisade Bio Welcomes Biopharmaceutical Industry Veterans Robert Baltera and Jordan Zwick to its Board of Directors
Read morePalisade Bio Welcomes Biopharmaceutical Industry Veterans Robert Baltera and Jordan Zwick to its Board of Directors
Read moreNew Form S-8 - PALISADE BIO, INC. <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001493152-26-028123 <b>Size:</b> 287 KB
Read morePalisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohns Disease at New York Academy of Sciences Symposium
Read more